Literature DB >> 10901148

Rapid and sensitive high-performance liquid chromatographic method for busulfan assay in plasma.

N Bleyzac1, P Barou, G Aulagner.   

Abstract

A reversed-phase liquid chromatographic method with ultraviolet detection has been developed to determine busulfan concentrations in plasma of children undergoing bone marrow transplantation. Plasma samples (200 microl) containing busulfan and 1,6-bis(methanesulfonyloxy)hexane as an internal standard were prepared by a simple derivatization method with diethyldithiocarbamate followed by extraction with ethyl acetate and solid-phase purification on C8 columns conditioned with methanol and water and eluted with acetonitrile (recovery 99%). Chromatography was accomplished using a Hypersil octadecylsilyl column (10 cm x 4.6 mm I.D.) and a mobile phase of acetonitrile, tetrahydrofuran and distilled water (65:5:30, v/v). The limit of detection was 25 ng/ml (signal-to-noise ratio of 5). Calibration curves were linear up to 25,000 ng/ml. Intra-day and inter-day coefficients of variation of the assay were < or =5%. This method was used to analyse busulfan plasma concentrations after oral administration within the framework of therapeutic drug monitoring and pharmacokinetic studies in children.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10901148     DOI: 10.1016/s0378-4347(00)00167-5

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  4 in total

1.  Should busulfan therapeutic range be narrowed in pediatrics? Experience from a large cohort of hematopoietic stem cell transplant children.

Authors:  M Philippe; S Goutelle; J Guitton; X Fonrose; C Bergeron; P Girard; Y Bertrand; N Bleyzac
Journal:  Bone Marrow Transplant       Date:  2015-09-21       Impact factor: 5.483

2.  HLA haploidentical hematopoietic cell transplantation using clofarabine and busulfan for refractory pediatric hematological malignancy.

Authors:  Masatoshi Takagi; Yasuyoshi Ishiwata; Yuki Aoki; Satoshi Miyamoto; Akihiro Hoshino; Kazuaki Matsumoto; Akira Nishimura; Mari Tanaka; Masakatsu Yanagimachi; Noriko Mitsuiki; Kohsuke Imai; Hirokazu Kanegane; Michiko Kajiwara; Kanako Takikawa; Tsukasa Mae; Osamu Tomita; Junya Fujimura; Masato Yasuhara; Daisuke Tomizawa; Shuki Mizutani; Tomohiro Morio
Journal:  Int J Hematol       Date:  2017-02-09       Impact factor: 2.490

3.  Accurately Achieving Target Busulfan Exposure in Children and Adolescents With Very Limited Sampling and the BestDose Software.

Authors:  Michael Neely; Michael Philippe; Teresa Rushing; Xiaowei Fu; Michael van Guilder; David Bayard; Alan Schumitzky; Nathalie Bleyzac; Sylvain Goutelle
Journal:  Ther Drug Monit       Date:  2016-06       Impact factor: 3.681

4.  Quantification of human plasma-busulfan concentration by liquid chromatography-tandem mass spectrometry.

Authors:  Soo Young Moon; Min Kyoo Lim; Susie Hong; Yongbum Jeon; Minje Han; Sang Hoon Song; Kyoung Soo Lim; Kyung-Sang Yu; In-Jin Jang; Ji Won Lee; Hyoung Jin Kang; Junghan Song
Journal:  Ann Lab Med       Date:  2013-12-06       Impact factor: 3.464

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.